Lane 1: HepG2
Lane 2: 293T
Recombinant Rabbit monoclonal primary
Recombinant GBA Monoclonal Antibody (ET1703-32)
SK-Br-3 cell lysate, A549 cell lysate, MCF-7 cell lysate, human breast carcinoma tissue, human liver tissue, human pancreas tissue, human kidney tissue, rat liver tissue, rat kidney tissue, mouse pancreas tissue.
Store at +4C after thawing. Aliquot store at -20C or -80C. Avoid repeated freeze / thaw cycles.
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Protein A affinity purified.
Acid beta glucosidase antibody; Acid beta-glucosidase antibody; Alglucerase antibody; Beta glucocerebrosidase antibody; BETA GLUCOSIDASE, ACID antibody; Beta-glucocerebrosidase antibody; betaGC antibody; D glucosyl N acylsphingosine glucohydrolase antibody; D-glucosyl-N-acylsphingosine glucohydrolase antibody; EC 126.96.36.199 antibody; GBA antibody; Gba protein antibody; GBA1 antibody; GC antibody; GCase antibody; GCB antibody; GLCM_HUMAN antibody; GLUC antibody; Glucocerebrosidase (alt.) antibody; Glucocerebrosidase antibody; GLUCOCEREBROSIDASE PSEUDOGENE antibody; Glucosidase beta antibody; Glucosidase, beta, acid antibody; Glucosidase, beta; acid (includes glucosylceramidase) antibody; Glucosylceramidase antibody; Imiglucerase antibody; Lysosomal glucocerebrosidase antibody; OTTHUMP00000033992 antibody; OTTHUMP00000033993 antibody
Belongs to the glycosyl hydrolase 30 family.
β-Glucosidase is a predominantly liver enzyme which efficiently hydrolyzes β-D-glucoside and β-D-galactoside. Defects in β-glucosidase cause Gaucher disease, an inherited condition distinguished by the accumulation of glucosylceramide within the cells of the reticuloendothelial system. β-Glucosidase is used in enzyme replacement treatment aimed at treating Gaucher disease. The absorption of dietary flavonoid glycosides in humans involves a critical deglycosylation step that is mediated by epithelial β-glucosidases.